SCHEMBL7428347

SCHEMBL7428347

CCc1ccccc1C(N)=C(C(=O)O)N(C)Cc1cccs1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.47
NPSR1 Q6W5P4 1/20 0.42
TSHR P16473 1/20 0.42
HSD11B1 P28845 6/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
CYP3A4 P08684 3/20 0.41
TRPM8 Q7Z2W7 3/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
MAPT P10636 1/20 0.40
POLB P06746 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HTT P42858 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7415245 0.82 NPC1 (0.50) RIPK1RAB9ASMN1; SMN2NPC1MAPT
SCHEMBL7428336 0.73 TRPM8 (0.47) RIPK1NPSR1HSD11B1RAB9ASMN1; SMN2
SCHEMBL12313812 0.69 RIPK1 (0.63) RIPK1NPSR1HSD11B1RAB9ASMN1; SMN2
SCHEMBL21400322 0.68 RIPK1 (0.62) RIPK1NPSR1HSD11B1RAB9ASMN1; SMN2
Carbamic Acid SCHEMBL27383793 0.68 POLB (0.55) RIPK1RAB9ASMN1; SMN2NPC1POLB
SCHEMBL13870657 0.68 RIPK1 (0.57) RIPK1NPSR1TSHRHSD11B1RAB9A
SCHEMBL6122487 0.67 RIPK1 (0.60) RIPK1NPSR1HSD11B1RAB9ASMN1; SMN2
SCHEMBL3325606 0.65 RIPK1 (0.66) RIPK1NPSR1HSD11B1RAB9ASMN1; SMN2
SCHEMBL3323893 0.65 RIPK1 (0.75) RIPK1NPSR1HSD11B1RAB9ASMN1; SMN2
SCHEMBL7093269 0.65 CLCN2 (0.40) NPSR1TSHRRAB9ANPC1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1265903-A1 THIEPINO[3,2-B]DIHYDROPYRIDINES AND RELATED COMPOSITIONS AND METHODS Ortho-Mcneil Pharmaceutical, Inc. (US) 2002-12-18 EP disclosed
US-6420383-B1 CALCIUM CHANNEL BLOCKERS, HYPERSENSITIVITY, ALLERGY, ASTHMA, BRONCHOSPASM, DYSMENORRHEA, ESOPHAGEAL SPASM, GLAUCOMA, PREMATURE LABOR, URINARY TRACT DISORDERS, GASTROINTESTINAL MOTILITY DISORDERS AND CARDIOVASCULAR DISORDERS. ORTHO-MCNEIL PHARMACEUTICAL, INC. 2002-07-16 US disclosed
WO-2001070748-A1 THIEPINO [3,2-b] DIHYDROPYRIDINES AND RELATED COMPOSITIONS AND METHODS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2001-09-27 WO disclosed